BioLineRx Ltd. Logo

BioLineRx Ltd.

BLRX | TA

Overview

Corporate Details

ISIN(s):
US09071M2052 (+1 more)
LEI:
529900AKIOSC15Y63R18
Country:
Israel
Address:
Modi'in Technology Park, 2 HaMa'ayan Street, 7177871 Modi'in
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

BioLineRx Ltd. develops and commercializes therapies for oncology and other critical diseases.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-14 16:01
Earnings Release
Second Quarter 2025 Financial Results and Provides Corporate Update
English 375.7 KB
2025-08-14 16:01
Foreign Filer Report
Second Quarter 2025 Financial Results and Provides Corporate Update
English 36.5 KB
2025-07-26 23:19
Prospectus
Immediate Report
English 397.4 KB
2025-07-26 23:19
Prospectus
Immediate Report
English 36.3 KB
2025-07-01 01:25
Foreign Filer Report
Immediate Report
English 127.3 KB
2025-07-01 01:25
Foreign Filer Report
Immediate Report
English 36.5 KB
2025-05-30 17:23
Foreign Filer Report
New Pilot Phase Data from Phase 2 Combination Trial of Motixafortide in First-L…
English 153.1 KB
2025-05-30 17:23
Foreign Filer Report
New Pilot Phase Data from Phase 2 Combination Trial of Motixafortide in First-L…
English 36.4 KB
2025-05-27 16:01
Foreign Filer Report
BioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate U…
English 430.8 KB
2025-05-27 16:01
Foreign Filer Report
BioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate U…
English 36.4 KB
2025-05-24 23:14
Proxy Solicitation & Information Statement
Immediate Report of Meeting to be held on June 29,2025,proxy statement
English 160.1 KB
2025-05-24 23:14
Foreign Filer Report
Immediate Report of Meeting to be held on June 29,2025,proxy statement
English 534.4 KB
2025-05-24 23:14
Pre-Annual General Meeting Information
Immediate Report of Meeting to be held on June 29,2025,proxy statement
English 100.8 KB
2025-04-14 13:22
Prospectus
PROSPECTUS SUPPLEMENT
English 415.1 KB
2025-04-14 13:22
Prospectus
PROSPECTUS SUPPLEMENT
English 36.2 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
GenSight Biologics S.A. Logo GenSight Biologics S.A. France SIGHT
Gentian Diagnostics ASA Logo Gentian Diagnostics ASA Norway GENT
Genus PLC Logo Genus PLC United Kingdom GNS
Grace Breeding Ltd. Logo Grace Breeding Ltd. Israel GRAC
Group 107 Ltd. Logo Group 107 Ltd. Israel G107
Guard Therapeutics International AB Logo Guard Therapeutics International AB Sweden GUARD
Gubra A/S Logo Gubra A/S Denmark GUBRA
Hadasit Bio Holding Ltd. Logo Hadasit Bio Holding Ltd. Israel HDST-M
Hansa Biopharma Logo Hansa Biopharma Sweden HNSA
HEMOGENYX PHARMACEUTICALS PLC Logo HEMOGENYX PHARMACEUTICALS PLC United Kingdom HEMO